Table 1 The clinical and pathological features of the patients
Features | MVI-(n = 41/43) | MVI + (n = 19/19) | p Value |
|---|---|---|---|
Sex | 0.276 | ||
Man | 30 (73.2%) | 17 (89.5%) | |
Woman | 11 (26.8%) | 2 (10.5%) | |
Age (year) | 0.116 | ||
< 52 | 30 (50%%) | 10 (16.7%) | |
3 52 | 11 (18.3%) | 9 (15%) | |
History of drinking | 0.813 | ||
Yes | 12 (29.3%) | 5 (26.3%) | |
No | 29 (70.7%) | 14 (73.7%) | |
History of smoking | 0.985 | ||
Yes | 15 (36.6%) | 7 (36.8%) | |
No | 26 (63.4%) | 12 (63.2%) | |
Cirrhosis | 0.287 | ||
Yes | 32 (78.0%) | 17 (89.5%) | |
No | 9 (22.0%) | 2 (10.5%) | |
CEA (ng/ml) | 0.908 | ||
> 5 | 2 (3.6%) | 1 (1.7%) | |
< 5 | 37 (66.1%) | 16 (28.6%) | |
Ca199 (u/ml) | 0.528 | ||
> 40 | 6 (10.5%) | 4 (7%) | |
= S40 | 33 (57.9%) | 14 (24.6%) | |
AFP (ng/ml) | 0.094 | ||
> 25 | 15 (25.9%) | 11 (19.0%) | |
25 (43.1%) | 7 (12.1%) | ||
ALT (u/l) | 0.003 | ||
> 40 | 5 (8.3%) | 9 (15%) | |
< 40 | 36 (60%) | 10 (16.6%) | |
AST (u/l) | |||
> 35 | 12 (20%) | 9 (15%) | 0.172 |
< 35 | 29 (48.3%) | 10 (16.7%) | |
GGT (u/l) | 0.052 | ||
> 40 | 17 (28.3%) | 13 (21.7%) | |
< 40 | 24 (40%) | 6 (10%) | |
Albumin (g/l) | 1.000 | ||
< 40 | 29 (48.3%) | 13 (21.7%) | |
> 40; < 55 | 12 (20%) | 6 (10%) | |
> 55 | 0 (0%) | 0 (0%) | |
HBV | 0.061 | ||
Yes | 22 (53.7%) | 15 (78.9%) | |
No | 19 (46.3%) | 4 (21.1%) | |
Pathology classification | 0.003 | ||
Low | 1 (2.3%) | 6 (31.6%) | |
Medium | 23 (53.5%) | 8 (42.1%) | |
High | 19 (44.2%) | 5 (26.3%) | |
Tumor size (cm) | 0.065 | ||
> 2.75 | 19 (31.7%) | 10 (16.6%) | |
< 2.75 | 22 (36.7%) | 9 (15%) |